EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pathway-selective Gi1, but not Gq, protein activation distinguishes hallucinogenic from non-hallucinogenic serotonin 5-HT2A receptor agonists in the human cortex

Patricia Miranda-Azpiazu, Rebeca Diez-Alarcia, Itziar Muneta-Arrate, Aintzane García-Bea, Rafael Maldonado, Benito Morentin, Javier González-Maeso, J Javier Meana

Neurochemistry International · 2026-11 · 106285

DOI: 10.1016/j.neuint.2026.106285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemistry International, 2026-11. Verfasst von Patricia Miranda-Azpiazu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of the Basque Country EHU, 48940, Leioa, Bizkaia, Spain. Electronic address: pm.azpiazu@gmail.com. Die Arbeit nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of the Basque Country.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The serotonin 5-HT2A receptor (5-HT2AR) signaling involves canonical Gq/11 proteins and alternative pathways, such as recruitment of other G proteins. It has been proposed that the 5-HT2AR-mediated activation of inhibitory Gi/o proteins accounts for the hallucinogenic properties of psychedelics. Here, the differential signaling patterns between hallucinogenic and non-hallucinogenic 5-HT2AR agonists were evaluated in post-mortem human prefrontal cortex using [35S]GTPγS binding assays coupled with antibody immunoprecipitation against different Gα protein subtypes. The hallucinogenic drugs (±)DOI, TCB-2, and LSD activated both Gq/11 and Gi1 proteins through 5-HT2ARs. In contrast, the non-hallucinogenic (±)DOI analogous Ariadne and the LSD analogous agonists 2-Br-LSD and lisuride, at similar concentrations, were inactive in 5-HT2AR-mediated activation of Gi1 proteins whereas activated Gq/11 proteins. Gi2, Go, Gq/11, Gs, and Gz proteins were also triggered by the agonists but through receptor targets other than 5-HT2ARs. The findings were confirmed using 5-HT2AR knock-out mouse brain tissue. The alkylating agent NEM attenuated agonist-mediated Gi1 protein activation with null effect on transduction through Gq/11 proteins, supporting the involvement of inhibitory G proteins in the activity of hallucinogenic 5-HT2AR drugs. In conclusion, Gi1 protein recruitment in human brain may be associated with the psychedelic properties of 5-HT2AR agonists. The results suggest the existence of differential signaling consistent with functional selectivity in the 5-HT2AR coupling to G proteins in the human brain, although a larger panel of drugs should be tested. These findings may help explain the differential behavioral responses elicited by psychedelic and non-psychedelic 5-HT2AR agonists.

Schlagwörter

Stichwörter der Autor:innen

5-HT(2A) receptorBiased agonismFunctional selectivityG proteinHallucinogensHuman brainPsychedelics

Autor:innen und Institutionen

  • Department of Pharmacology, University of the Basque Country EHU, 48940, Leioa, Bizkaia, Spain. Electronic address: pm.azpiazu@gmail.com.
  • Department of Pharmacology, University of the Basque Country EHU, 48940, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III, CIBERSAM, Spain; Biobizkaia Health…
  • Department of Pharmacology, University of the Basque Country EHU, 48940, Leioa, Bizkaia, Spain. Electronic address: itziar.munetaarrate@unige.ch.
  • Department of Pharmacology, University of the Basque Country EHU, 48940, Leioa, Bizkaia, Spain. Electronic address: agarciabea@faes.es.
  • Laboratory of Neuropharmacology - Neurophar, Department of Medicine and Life Sciences, University Pompeu Fabra UPF, 08003, Barcelona, Spain; Hospital del Mar Medical Research Institute (IMIM), 08003, Barcelona, Spain. E…
  • Biobizkaia Health Research Institute, 48903, Barakaldo, Bizkaia, Spain; Service of Forensic Pathology, Basque Institute of Legal Medicine, 48001, Bilbao, Spain. Electronic address: morentin.b@justizia.eus.

Förderung

  • University of the Basque Country

Zitieren

APA

Miranda-Azpiazu, P., Diez-Alarcia, R., Muneta-Arrate, I., García-Bea, A., Maldonado, R., Morentin, B., González-Maeso, J., & Meana, J. J. (2026). Pathway-selective Gi1, but not Gq, protein activation distinguishes hallucinogenic from non-hallucinogenic serotonin 5-HT2A receptor agonists in the human cortex. Neurochemistry International, 106285. https://doi.org/10.1016/j.neuint.2026.106285

Vancouver

Miranda-Azpiazu P, Diez-Alarcia R, Muneta-Arrate I, García-Bea A, Maldonado R, Morentin B, et al. Pathway-selective Gi1, but not Gq, protein activation distinguishes hallucinogenic from non-hallucinogenic serotonin 5-HT2A receptor agonists in the human cortex. Neurochemistry International. 2026:106285. doi:10.1016/j.neuint.2026.106285

BibTeX
@article{MirandaAzpiazu2026,
  author = {Miranda-Azpiazu, Patricia and Diez-Alarcia, Rebeca and Muneta-Arrate, Itziar and García-Bea, Aintzane and Maldonado, Rafael and Morentin, Benito and González-Maeso, Javier and Meana, J Javier},
  title = {Pathway-selective Gi1, but not Gq, protein activation distinguishes hallucinogenic from non-hallucinogenic serotonin 5-HT2A receptor agonists in the human cortex},
  journal = {Neurochemistry International},
  year = {2026},
  pages = {106285},
  doi = {10.1016/j.neuint.2026.106285}
}
Kostenlos starten →